The Potential Predictive Biomarkers for Advanced Hepatocellular Carcinoma Treated With Anti-Angiogenic Drugs in Combination With PD-1 Antibody

BACKGROUND: Based on molecular biomarkers, anti-angiogenic drugs in combination with programmed cell death protein 1 (PD-1) antibodies can screen the potentially beneficial populations with hepatocellular carcinoma (HCC) and predict the efficacy after treatment. Therefore, we aimed to study predicti...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chenxi, Zhu, Sihui, Dong, Yanbing, Shao, Jie, Liu, Baorui, Shen, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301374/
https://www.ncbi.nlm.nih.gov/pubmed/35874743
http://dx.doi.org/10.3389/fimmu.2022.930096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301374/
https://www.ncbi.nlm.nih.gov/pubmed/35874743
http://dx.doi.org/10.3389/fimmu.2022.930096

Ejemplares similares